A Clinical Trial of S-1 Plus Cisplatin Versus 5-FU Plus Cisplatin in Patients With Unresectable or Advanced Gastric Cancer.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- 04 Jun 2013 Primary endpoint 'Time-to-disease-progression' has been met.
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 27 May 2013 Status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History